News
Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...
Novo Nordisk’s Lars Fruergaard Jørgensen will step down as CEO of the weight-loss drug maker following a steep decline in ...
Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results